MPB-GT patients were infused with higher amount of primitive and myeloid progenitors than BM-GT subjects
In order to assess the behavior of the two distinct HSPC sources after GT we analyzed 13 pediatric WAS-GT patients receiving either BM (Characteristics of the WAS-GT patients included in the studyG-CSF+PlerixaforG-CSF+PlerixaforG-CSF+PlerixaforG-CSF+PlerixaforG-CSF+PlerixaforG-CSF+Plerixafor% of transduction(% of LV+ colonies)Data from Pt1 to Pt9 have been previously described